Taysha Gene Therapies commences underwritten public offering

1 day ago 1

Taysha Gene Therapies (NASDAQ:TSHA) has commenced an underwritten public offering of shares of common stock and pre-funded warrants to purchase shares of its common stock.
All the securities will be offered by Taysha.
Taysha also intends to grant the underwriters

Recommended For You